Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis.
about
Dominant-negative effect of truncated mannose 6-phosphate/insulin-like growth factor II receptor species in cancerEndoplasmic reticulum degradation impedes olfactory G-protein coupled receptor functional expressionbeta-Arrestin 1 and 2 differentially regulate heptahelical receptor signaling and traffickingCoupling of heterotrimeric Gi proteins to the erythropoietin receptor.Proteasome involvement in agonist-induced down-regulation of mu and delta opioid receptors.Albuterol as an adjunctive treatment to enzyme replacement therapy in infantile-onset Pompe disease.Human beta1-adrenergic receptor is subject to constitutive and regulated N-terminal cleavageStructure and regulation of opioid receptors.Six weeks of voluntary wheel running modulates inflammatory protein (MCP-1, IL-6, and IL-10) and DAMP (Hsp72) responses to acute stress in white adipose tissue of lean rats.A C-terminal tyrosine-based motif in the bile salt export pump directs clathrin-dependent endocytosis.COOH-terminal truncations promote proteasome-dependent degradation of mature cystic fibrosis transmembrane conductance regulator from post-Golgi compartments.Lentivirus vector-mediated Rho guanine nucleotide dissociation inhibitor 2 overexpression induces beta-2 adrenergic receptor desensitization in airway smooth muscle cells.Insight into the mechanism of dopamine D1-like receptor activation. Evidence for a molecular interplay between the third extracellular loop and the cytoplasmic tail.Reduced cell surface expression of CCR5 in CCR5Delta 32 heterozygotes is mediated by gene dosage, rather than by receptor sequestration.The natural inverse agonist agouti-related protein induces arrestin-mediated endocytosis of melanocortin-3 and -4 receptors.Resistance of the human beta1-adrenergic receptor to agonist-induced ubiquitination: a mechanism for impaired receptor degradation.Subtype specific internalization of P2Y1 and P2Y2 receptors induced by novel adenosine 5'-O-(1-boranotriphosphate) derivatives.Methods of measuring internalization of G protein-coupled receptors.Agonist-dependent up-regulation of thyrotrophin-releasing hormone receptor protein.Role of the cyclic AMP-dependent protein kinase in homologous resensitization of the beta1-adrenergic receptor.Phosphorylation and chronic agonist treatment atypically modulate GABAB receptor cell surface stability.Differential sorting of human delta-opioid receptors after internalization by peptide and alkaloid agonists.The extracellular N terminus of the endothelin B (ETB) receptor is cleaved by a metalloprotease in an agonist-dependent process.A transplantable sorting signal that is sufficient to mediate rapid recycling of G protein-coupled receptors.A phosphorylation-regulated brake mechanism controls the initial endocytosis of opioid receptors but is not required for post-endocytic sorting to lysosomes.Agonist-induced long-term desensitization of the human prostacyclin receptor.Resistance of the human beta 1-adrenergic receptor to agonist-mediated down-regulation. Role of the C terminus in determining beta-subtype degradation.Trafficking, ubiquitination, and down-regulation of the human platelet-activating factor receptor.The myocardium-protective Gly-49 variant of the beta 1-adrenergic receptor exhibits constitutive activity and increased desensitization and down-regulation.G protein-coupled receptors desensitize and down-regulate epidermal growth factor receptors in renal mesangial cells.A membrane-proximal basic domain and cysteine cluster in the C-terminal tail of CCR5 constitute a bipartite motif critical for cell surface expression.Antidepressant-induced switch of beta 1-adrenoceptor trafficking as a mechanism for drug action.Ca2+ -dependent down-regulation of human histamine H1 receptors in Chinese hamster ovary cells.
P2860
Q24337644-F7B20BDB-D9E7-43F3-9987-47695956CA4BQ24795923-B33C8AE0-E0F0-4EA3-9A09-EED4A9893D8AQ28507206-9B26C0DE-76AC-4362-BDC0-9F7341B58FB4Q30951776-9575D694-9F0F-46A2-A5C4-4226922088A3Q31816606-77AC3F8D-D1B5-49EF-B9F5-47AEBC12E35DQ33606805-583B0FE6-60C0-4CC1-A68C-400EE9A32399Q34121376-BD057EE4-5EAA-480A-A032-BF9B43137039Q34136307-4EFEC0E6-47EE-4E03-A1EE-857C3772EF31Q34994713-661F1564-2AD6-4519-BCEF-3C6AD0F0D517Q35871064-F58B9416-92D6-4B90-BC18-41A9DF781894Q36326371-EC0B5639-2674-4FC0-9E96-10C2184FA5ADQ37274582-26E2E999-DB76-46BB-98CC-33A9831ADD94Q38359032-60011771-B1E6-40D2-B4B5-29DBF7E1F735Q39556857-13E58927-954D-4139-8FA4-4367D81022C2Q40220162-8D741524-EE35-4227-9F97-84E630F26D03Q40522065-F2348C70-760D-441A-A393-BF217B8C82BCQ40545348-FA97492D-B2DB-4BED-9AAF-084DD6D12020Q40561392-A909AF03-EDC6-4B3B-9486-EA3332C577E2Q40577854-E2CDA265-209A-42CE-ADF8-95E8F2F04246Q40584663-E99D73BA-477D-42B5-8B2E-01B0187A6063Q40602008-A7E8B7C1-2932-4733-9E4C-959F28D81D76Q40658880-CA4BE0EC-559E-4634-9760-3133C16B6BA6Q40704613-8202197F-E020-49E6-9E68-964A0CCF4A67Q40780105-59C3639D-571D-4D5D-A06B-74C79FF5043DQ40793951-4C7B4EC0-07F3-4004-AA6A-7AE1AA217FF8Q40842393-947DD451-12B2-45B7-BDF3-48E5EFA40B83Q42445328-40DEC39C-0052-4636-B14B-F16EC3173440Q42450377-13B780A5-A6CA-421B-96B9-615E66FD3A47Q42521824-B2586A63-902E-430D-A892-52CA1A170E54Q43616468-D8DAC551-94E9-47DF-8F0B-E1398F8E4BF3Q43714142-757B9C3C-D3D7-4F87-B888-10F5F27708B6Q44189940-EC30A227-1CE5-47CD-BDA9-281E206C625EQ47611848-F1FDD3D2-43C9-46B5-8BFE-2AD7760CEF22
P2860
Beta(2)-adrenergic receptor down-regulation. Evidence for a pathway that does not require endocytosis.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Beta(2)-adrenergic receptor do ...... does not require endocytosis.
@en
type
label
Beta(2)-adrenergic receptor do ...... does not require endocytosis.
@en
prefLabel
Beta(2)-adrenergic receptor do ...... does not require endocytosis.
@en
P2093
P2860
P50
P356
P1476
Beta(2)-adrenergic receptor do ...... t does not require endocytosis
@en
P2093
A D Strosberg
A Da Silva
P2860
P304
28900-28908
P356
10.1074/JBC.274.41.28900
P407
P577
1999-10-01T00:00:00Z